HC Wainwright & Co. Reiterates Neutral on Zura Bio, Maintains $5 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated a Neutral rating for Zura Bio (NASDAQ:ZURA) and maintained a $5 price target.
October 21, 2024 | 10:27 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
HC Wainwright & Co. has reiterated a Neutral rating for Zura Bio and maintained a $5 price target, indicating no expected significant short-term price movement.
The reiteration of a Neutral rating and maintenance of the $5 price target by HC Wainwright & Co. suggests that the analyst does not foresee significant changes in Zura Bio's stock price in the short term. This indicates a stable outlook without any major catalysts for upward or downward movement.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100